Two long-term, CIDR-based estrus synchronization protocols were evaluated among Bos indicus-influenced and Bos taurus beef heifers. Treatments were evaluated on the basis of estrous response and pregnancy rate resulting from fixed-time artificial insemination (FTAI), and these outcomes were analyzed retrospectively relative to reproductive tract score (RTS; Scale 1-5) at treatment initiation. Estrus was synchronized for 1139 heifers in three locations, and heifers were assigned to one of two treatments within each location based on RTS. Heifers assigned to the 14-d CIDR-PG protocol received a controlled internal drug release (CIDR) insert (1.38 g progesterone) on Day 0, CIDR removal on Day 14, administration of prostaglandin F (PG; 25 mg im) on Day 30, and administration of gonadotropin-releasing hormone (GnRH; 100 μg im) concurrent with FTAI on Day 33, 66 h after PG. Heifers assigned to the 9-d CIDR-PG protocol received administration of PG concurrent with CIDR insertion on Day 5, administration of PG concurrent with CIDR removal on Day 14, administration of PG on Day 30, and administration of GnRH concurrent with FTAI on Day 33, 66 h after PG. Estrus detection aids were applied at CIDR removal on Day 14 and at PG on Day 30 to evaluate estrous response rate. Mean RTS differed (P < 0.0001) based on biological type due to higher rates of estrous cyclicity (RTS 4 and 5) among Bos taurus heifers (72%; 416/574) than among Bos indicus-influenced heifers (27%; 150/565). The proportion of heifers expressing estrus following CIDR removal was greater (P = 0.01) among heifers assigned to the 14-d CIDR-PG treatment (88%; 492/559) compared to the 9-d CIDR-PG treatment (83%; 480/580). Estrous response following CIDR removal was also higher (P < 0.0001) among Bos taurus (95%; 547/574) compared to Bos indicus-influenced (75%; 425/565) heifers. Rate of estrous response prior to FTAI did not differ significantly based on treatment but was higher (P < 0.0001) among Bos taurus heifers (60%; 344/574) than among Bos indicus-influenced heifers (45%; 253/565). However, the effect of biological type on estrous response was not significant when RTS was included in the model, as RTS significantly (P < 0.0001) affected the rate of estrous response both at CIDR removal and prior to FTAI. Across treatments and biological types, heifers that expressed estrus prior to AI achieved higher (P < 0.0001) AI pregnancy rates than heifers failing to express estrus. Pregnancy rates to FTAI did not differ significantly based on treatment in either biological type. Higher rates of estrous cyclicity among Bos taurus heifers resulted in higher FTAI pregnancy rates among Bos taurus (51%; 290/574) compared to Bos indicus-influenced heifers (39%; 218/565). However, pregnancy rates of respective RTS did not differ based on biological type. In summary, long-term CIDR-based protocols provide a simple, effective method of estrus synchronization in Bos indicus-influenced and Bos taurus beef heifers. Moreover, these results highlight the importance of management practices that result in high rates of estrous cyclicity prior to protocol initiation, particularly among later maturing breeds and biological types.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.theriogenology.2017.01.020DOI Listing

Publication Analysis

Top Keywords

day administration
20
heifers assigned
12
cidr removal
12
removal day
12
day
10
14-d cidr-pg
8
9-d cidr-pg
8
bos indicus-influenced
8
indicus-influenced bos
8
bos taurus
8

Similar Publications

Mannose oligosaccharide (MOS) has been shown to promote animal growth, maintain intestinal health, and activate the intestinal immune system. However, the question of whether MOS can stimulate the immune system and alleviate acetylsalicylic acid (ASA)-induced gut damage remains unresolved. The purpose of this study was to investigate the impact of MOS pretreatment on the immunological and anti-inflammatory capabilities of rats with ASA-induced intestinal injury.

View Article and Find Full Text PDF

Background: Regenerative endodontics requires an innovative delivery system to release antibiotics/growth factors in a sequential trend. This study focuses on developing/characterizing a thermoresponsive core-shell hydrogel designed for targeted drug delivery in endodontics.

Methods: The core-shell chitosan-alginate microparticles were prepared by electrospraying to deliver bone morphogenic protein-2 for 14 days and transforming growth factor-beta 1 (TGF-β1) for 7-14 days.

View Article and Find Full Text PDF

Melatonin is commonly used to treat sleep disorders. Regardless of the prolactin level elevation induced by melatonin administration, breast budding is not known to develop as a result of this treatment. A 10-year-old boy presented to our outpatient clinic with restlessness and sleep disorders.

View Article and Find Full Text PDF

A 35-year-old male patient with acute myeloid leukemia (AML), with hyperleukocytosis, presented with acute myocardial infarction. The individual had acute onset chest pain and reached the hospital within the window period. His electrocardiogram (ECG) revealed ST elevated myocardial infarction (STEMI), ST elevated myocardial infarction, and thrombolysis was performed.

View Article and Find Full Text PDF

Antithrombotic medications, including antiplatelet agents, are standard treatments for patients with hyperlipidemia who have a high risk of developing cardiovascular disease (CVD). The ongoing exploration of new antiplatelet agents with minimal bleeding effects is crucial, including the investigation of potential compounds derived from natural products. This study intended to evaluate the antiplatelet effects of a combined extract of sappan wood ( L.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!